Združene države Amerike - angleščina - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - azithromycin monohydrate (unii: jte4mnn1md) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of azithromycin tablets and other antibacterial drugs, azithromycin tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see dosage and administration ( 2)] - acute bacterial exacerbations of chronic bronchitis due to

Združene države Amerike - angleščina - NLM (National Library of Medicine)

proficient rx lp - azithromycin monohydrate (unii: jte4mnn1md) (azithromycin anhydrous - unii:j2klz20u1m) - azithromycin anhydrous 250 mg - acute bacterial exacerbations of chronic obstructive pulmonary disease due to haemophilus influenzae, moraxella catarrhalis or streptococcus pneumoniae. acute bacterial sinusitis due to haemophilus influenzae, moraxella catarrhalis or streptococcus pneumoniae . community-acquired pneumonia due to chlamydophila pneumoniae, haemophilus influenzae, mycoplasma pneumoniae or streptococcus pneumoniae in patients appropriate for oral therapy. note: azithromycin should not be used in patients with pneumonia who are judged to be inappropriate for oral therapy because of moderate to severe illness or risk factors such as any of the following: pharyngitis/tonsillitis caused by streptococcus pyogenes as an alternative to first-line therapy in individuals who cannot use first-line therapy. uncomplicated skin and skin structure infections due to staphylococcus aureus, streptococcus pyogenes, or streptococcus agalactiae. abscesses usually require surgical drainage. urethritis and cervicitis due to chlamydia tr

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

apotex nz ltd - azithromycin dihydrate 261.02mg equivalent to 250 mg azithromycin - film coated tablet - 250 mg - active: azithromycin dihydrate 261.02mg equivalent to 250 mg azithromycin excipient: calcium hydrogen phosphate dihydrate croscarmellose sodium hyprolose magnesium stearate opadry white 31k58875 purified water - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. chlamydia trachomatis conjunctivitis and trachoma. 5. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. azithromycin is indicated for use in children for the treatment of the following infections: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. 5. acute streptococcal pharyngitis/tonsillitis. 6. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. the 20 mg/kg azithromycin dose appears to be as effective as penicillin in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 7. chlamydia trachomatis conjunctivitis and trachoma in children 12 months or older.

Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

apotex nz ltd - azithromycin dihydrate 522.04mg equivalent to 500 mg azithromycin - film coated tablet - 500 mg - active: azithromycin dihydrate 522.04mg equivalent to 500 mg azithromycin excipient: calcium hydrogen phosphate dihydrate croscarmellose sodium hyprolose magnesium stearate opadry white 31k58875 purified water - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. chlamydia trachomatis conjunctivitis and trachoma. 5. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. azithromycin is indicated for use in children for the treatment of the following infections: 1. lower respiratory tract infections (acute bacterial bronchitis, community acquired pneumonia). 2. upper respiratory tract infections (acute sinusitis, acute streptococcal pharyngitis, acute otitis media). 3. uncomplicated skin and skin structure infections (uncomplicated infections, sexually transmitted diseases, pelvic inflammatory disease). 4. prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease. 5. acute streptococcal pharyngitis/tonsillitis. 6. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. the 20 mg/kg azithromycin dose appears to be as effective as penicillin in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 7. chlamydia trachomatis conjunctivitis and trachoma in children 12 months or older.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - azithromycin dihydrate, quantity: 524.05 mg (equivalent: azithromycin, qty 500 mg) - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; hyprolose; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin - apo-azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity:,1. lower respiratory tract infections:,? acute bacterial bronchitis due to streptococcus pneumoniae, haemophilus influenzae or moraxella catarrhalis. ? community acquired pneumonia due to streptococcus pneumoniae or haemophilus influenzae in patients suitable for outpatient oral treatment. ? community acquired pneumonia caused by susceptible organisms in patients who require initial intravenous therapy. in clinical studies efficacy has been demonstrated against chlamydia pneumoniae, haemophilus influenzae, legionella pneumophilia, moraxella catarrhalis, mycoplasma pneumoniae, staphylococcus aureus and streptococcus pneumoniae.,2. upper respiratory tract infections:,? acute sinusitis due to streptococcus pneumoniae or haemophilus influenzae. ? acute streptococcal pharyngitis. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. azithromycin appears to be almost as effective in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present.,3. uncomplicated skin and skin structure infections:,? uncomplicated infections due to staphylococcus aureus, streptococcus pyogenes or streptococcus agalactiae. abscesses usually require surgical drainage.,4. sexually transmitted diseases: uncomplicated urethritis and cervicitis due to chlamydia trachomatis.,? note: at the recommended dose azithromycin cannot be relied upon to treat gonorrhoea or syphilis. as with other drugs for the treatment of non-gonococcal infections, it may mask or delay the symptoms of incubating gonorrhoea or syphilis. appropriate tests should be performed for the detection of gonorrhoea or syphilis and treatment should be instituted as required. ? apo-azithromycin is also indicated for the treatment of chlamydia trachomatis conjunctivitis and trachoma.

Izrael - angleščina - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - powder for suspension - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms :in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Izrael - angleščina - Ministry of Health

teva pharmaceutical industries ltd, israel - azithromycin - powder for suspension - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms : in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azithromycin dihydrate, quantity: 524.1 mg (equivalent: azithromycin, qty 500 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; maize starch; sodium lauryl sulfate; sodium starch glycollate type a; colloidal anhydrous silica; lactose monohydrate; hypromellose; titanium dioxide; macrogol 4000 - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections: acute bacterial bronchitis due to streptococcus pneumoniae, haemophilus influenzae or moraxella catarrhalis.community acquired pneumonia due to streptococcus pneumoniae or haemophilus influenzae in patients suitable for outpatient oral treatment. community acquired pneumonia caused by susceptible organisms in patients who require initial intravenous therapy. in clinical studies efficacy has been demonstrated against chlamydia pneumoniae, haemophilus influenzae, legionella pneumophilia, moraxella catarrhalis, mycoplasma pneumoniae, staphylococcus aureus and streptococcus pneumoniae. 2. upper respiratory tract infections: acute sinusitis due to streptococcus pneumoniae or haemophilus influenzae. acute streptococcal pharyngitis. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. azithromycin appears to be almost as effective in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 3. uncomplicated skin and skin structure infections: uncomplicated infections due to staphylococcus aureus, streptococcus pyogenes or streptococcus agalactiae. abscesses usually require surgical drainage. 4. sexually transmitted diseases: uncomplicated urethritis and cervicitis due to chlamydia trachomatis. . note: at the recommended dose azithromycin cannot be relied upon to treat gonorrhoea or syphilis. as with other medicines for the treatment of non-gonococcal infections, it may mask or delay the symptoms of incubating gonorrhoea or syphilis. appropriate tests should be performed for the detection of gonorrhoea or syphilis and treatment should be instituted as required. azithromycin is also indicated for the treatment of chlamydia trachomatis conjunctivitis and trachoma. azithromycin is also indicated for the prevention of infection due to mycobacterium avium-intracellular complex (mac) disease, when used as the sole agent or in combination with rifabutin at its approved dose, in adults and children aged more than 12 years with hiv infection and cd4 cell count less than or equal to 75 cells/microliter (see precautions). disseminated infection due to mycobacterium avium-intracellular complex should be excluded by a negative blood culture prior to commencement of therapy.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - azithromycin dihydrate, quantity: 524.1 mg (equivalent: azithromycin, qty 500 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; magnesium stearate; maize starch; sodium lauryl sulfate; lactose monohydrate; hypromellose; titanium dioxide; macrogol 4000 - azithromycin is indicated for use in adults for the treatment of the following infections of mild to moderate severity: 1. lower respiratory tract infections: acute bacterial bronchitis due to streptococcus pneumoniae, haemophilus influenzae or moraxella catarrhalis.community acquired pneumonia due to streptococcus pneumoniae or haemophilus influenzae in patients suitable for outpatient oral treatment. community acquired pneumonia caused by susceptible organisms in patients who require initial intravenous therapy. in clinical studies efficacy has been demonstrated against chlamydia pneumoniae, haemophilus influenzae, legionella pneumophilia, moraxella catarrhalis, mycoplasma pneumoniae, staphylococcus aureus and streptococcus pneumoniae. 2. upper respiratory tract infections: acute sinusitis due to streptococcus pneumoniae or haemophilus influenzae. acute streptococcal pharyngitis. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. azithromycin appears to be almost as effective in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 3. uncomplicated skin and skin structure infections: uncomplicated infections due to staphylococcus aureus, streptococcus pyogenes or streptococcus agalactiae. abscesses usually require surgical drainage. 4. sexually transmitted diseases: uncomplicated urethritis and cervicitis due to chlamydia trachomatis. . note: at the recommended dose azithromycin cannot be relied upon to treat gonorrhoea or syphilis. as with other medicines for the treatment of non-gonococcal infections, it may mask or delay the symptoms of incubating gonorrhoea or syphilis. appropriate tests should be performed for the detection of gonorrhoea or syphilis and treatment should be instituted as required. azithromycin is also indicated for the treatment of chlamydia trachomatis conjunctivitis and trachoma. azithromycin is also indicated for the prevention of infection due to mycobacterium avium-intracellular complex (mac) disease, when used as the sole agent or in combination with rifabutin at its approved dose, in adults and children aged more than 12 years with hiv infection and cd4 cell count less than or equal to 75 cells/microliter (see precautions). disseminated infection due to mycobacterium avium-intracellular complex should be excluded by a negative blood culture prior to commencement of therapy.

Izrael - angleščina - Ministry of Health

mbi pharma ltd., israel - azithromycin as dihydrate - powder for solution for infusion - azithromycin as dihydrate 500 mg - azithromycin - treatment of infections caused by susceptible strains of the designated microorganisms in the following conditions: community-acquired pneumonia and pelvic inflammatory disease.